WallStSmart

Churchill Capital Corp XI (CCXI)vsInvest Green Acquisition Corporation (IGAC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

IGAC leads profitability with a 0.0% profit margin vs 0.0%. CCXI earns a higher WallStSmart Score of 23/100 (F).

CCXI

Avoid

23

out of 100

Grade: F

Growth: 4.3Profit: 3.5Value: 5.0Quality: 4.0
Piotroski: 2/9

IGAC

Avoid

21

out of 100

Grade: F

Growth: 3.7Profit: 3.5Value: 5.3Quality: 5.3
Piotroski: 3/9Altman Z: 5.32

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCXI0 strengths · Avg: 0/10

No standout strengths identified

IGAC1 strengths · Avg: 10.0/10
Altman Z-ScoreHealth
5.3210/10

Safe zone — low bankruptcy risk

Areas to Watch

CCXI4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$746.38M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

IGAC4 concerns · Avg: 3.5/10
P/E RatioValuation
25.3x4/10

Moderate valuation

Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

Market CapQuality
$101.56M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : CCXI

CCXI has a balanced fundamental profile.

Bull Case : IGAC

The strongest argument for IGAC centers on Altman Z-Score.

Bear Case : CCXI

The primary concerns for CCXI are Revenue Growth, EPS Growth, Market Cap.

Bear Case : IGAC

The primary concerns for IGAC are P/E Ratio, Revenue Growth, Market Cap.

Key Dynamics to Monitor

IGAC is growing revenue faster at 0.0% — sustainability is the question.

CCXI generates stronger free cash flow (-157,581), providing more financial flexibility.

Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CCXI scores higher overall (23/100 vs 21/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Churchill Capital Corp XI

FINANCIAL SERVICES · SHELL COMPANIES · USA

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.

Invest Green Acquisition Corporation

FINANCIAL SERVICES · SHELL COMPANIES · USA

IG Acquisition Corp. The company is headquartered in New York, New York.

Want to dig deeper into these stocks?